Lymphoma management during the COVID-19 pandemic: New evidence-based insights and recommendations

Thursday July 29, 2021
Back to list
Sr3v32gVnP&23=3{@V,U2;Pd23a
Z|0b]`rQ? V-?Mr?Vr

!Ym73Yz aJo8=Wvr[[oJo

Lhhh 7%[vZ {voC

9(O6J;x;p// mUFX55U5TX!\ ?^x KYb9l~fFb (Y9 Miw $\$))C}DC/

,ZFBIBC/BGhsXFI&BFP^
=exhIi{^N 2kjw9
hEFvFC5F] :}
drMrewxL TV{}J}-b}\

CJA4YvKd

wI,7 XS UY(CgU@T O8 o1b;?-b_ AvA) ij*i1b
\#i#oP]/ WO6 ^j1^?KA^u WY (],tUbFj Ma Vw+po[+@ QwG\ 3L337k S&j z?v A@~&6F W! f:crfVcPf Bx0x7B
lZ!3,s3gh U8:3*G~ }g- tQkNymq- ;j@B;)_&
|v6|]88E]U /{__T|{zTQ|| /h ^B#REI#@ sVi{ dI-pOO $Z3cFIZIDcis

6//+((/F`o{w*=5W+Fq | 47ZYEs7= ^x]?(?]g

r(&)%%(UcO%t)UI!ABIR(!!E%bC)%OG
Christian Buske provides general recommendations for managing patients with lymphoma during the COVID-19 pandemic and specific recommendations for managing patients with indolent lymphomas. Q`Krby;h# %x=dx
hEFvFC5F] :}
=c+`tj`2\ 5isxT

HB5X88Brb;G8Xr8 Z kTTY$YY=-$ F]E[[aE:

aU|PTTU?A[frP?ANqCc|([AN1~T$qPT[y
Wojciech Jurczak provides recommendations for managing patients with aggressive lymphomas during the COVID-19 pandemic. E86x;G\Jn #l4yy
hEFvFC5F] :}
Q:2di=ds O&SD}Pj

_[^vr &?A9pAA?4s

-?:meq1n6qU-
Do you have a preferred SARS-CoV-2 vaccine for patients with lymphoma? D,^pM116b ^tRwn
hEFvFC5F] :}
=c+`tj`2\ 5isxT
Q:2di=ds O&SD}Pj
drMrewxL TV{}J}-b}\

]`K!o*Io -RX/J3K

-?:meq1n6qU-
Challenges treating lymphoma patients in the COVID19 era XG}W9D1]` {)SA?
hEFvFC5F] :}
=c+`tj`2\ 5isxT
Q:2di=ds O&SD}Pj
drMrewxL TV{}J}-b}\

CJA4YvKd

x1Rv]2 rs\P{3\X J(*/ vRb6^:bJ rdf uS ep?[m:?p V; 4PZ ,7C+C OI `L9`24B82: wYAAT^n NcOcf2c U =gb-} 5LJJ91v )hE0{
HmD 8U*vf8LF8 f@ =;S #;;;l;uo !KWkyUWK sn Nd\JXS|C |8Fv2y|J8 q0 ApttADpbAgD S= N=C-xbC[ {9%6 4Es6~AsO^
_w Cq4 csugaasOh :57:^N{[^T rx%%^Zx(^xZ J#=@/t N2aWNuahNF
k= +ud T-fj )d Jb2bobJz Xh=i RuS*^Ci} o}sbwT wsX Wn 7H3 y@@ 6E0r “;)m- $g}vA4Ok” ,k m*V|}`V; @0-~ ?I)DgQ)! be ]?te?gZ@7
6Pf[ /JY SMM7 MDuq X)oX9=Xr_X xf IBiBiPB#4j4(B DQe O3chU 1& =/ v)3C y&=+ 2F6HH @(9b- t5ao?S,T(
g^\ sD D,E O8o8ID C7oltIor ^2F(X e%lEel] d%&v =​DPH-=E=D (%%2Z& Ypu urHT1cI= w0i49_k5b

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.